In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...